Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol-lowering therapy: what patients expect in return

W W Reed1, J E Herbers, G L Noel

  • 1Department of Medicine, Walter Reed Army Medical Center, Washington, DC.

Journal of General Internal Medicine
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do general internal medicine fellows find jobs that match their training?

Journal of general internal medicine·1998
Same author

Learning from the last ultrasound. A population-based study of patients with abdominal aortic aneurysm.

Archives of internal medicine·1997
Same author

Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis.

The Western journal of medicine·1996
Same author

When the physician leaves the patient: predictors of satisfaction with the transfer of care in a primary care clinic.

Journal of general internal medicine·1995
Same author

One-year outcome for patients with a chief complaint of dizziness.

Journal of general internal medicine·1994
Same author

Evaluating chest pain. The patient's presentation style alters the physician's diagnostic approach.

Archives of internal medicine·1993

Patient preferences for cholesterol-lowering therapy vary significantly. Many patients expect little benefit, while others may not receive adequate value for their treatment adherence.

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Patient-Reported Outcomes

Background:

  • Cholesterol-lowering therapies are widely prescribed for cardiovascular disease prevention.
  • Understanding patient values and preferences is crucial for optimizing treatment adherence and outcomes.
  • Significant variability exists in how patients perceive the benefits and risks of long-term medication.

Purpose of the Study:

  • To quantify the range of patient values and preferences concerning cholesterol-lowering therapy.
  • To identify potential discrepancies between patient expectations and therapeutic benefits.

Main Methods:

  • A descriptive study design was employed.
  • Thirty-five patients on cholesterol-lowering therapy for at least three months were interviewed.

Related Experiment Videos

  • Utility assessment utilized the time tradeoff and standard reference gamble techniques.

    • Main Results:

    • Using the time tradeoff method, 34% of patients valued less than one month of life as adequate compensation for lifelong therapy, while 11% required at least five years.
    • The standard reference gamble revealed that 51% of patients would not accept a 1 in 1000 risk of death for normal life expectancy off therapy.
    • Conversely, 40% would accept a 1% or greater risk of death to avoid therapy.

    Conclusions:

    • Patient expectations for cholesterol-lowering therapy show considerable heterogeneity.
    • A substantial proportion of patients may have unrealistic expectations or perceive inadequate benefits relative to the burdens of therapy.
    • These findings highlight the need for personalized patient counseling regarding the expected outcomes of cholesterol-lowering treatments.